Tarcic Gabi
Chief Development Officer
Tarcic Gabi has filed 1 SEC Form 4 filing (1 transaction rows) across 1 company, with disclosures dating back to 2026. 1 of those filings fall inside the rolling window. Most recent filing: Aug 26, 2026.
On the most recent filing, Tarcic Gabi is listed as Chief Development Officer at Evogene Ltd. Inside the rolling window, Tarcic Gabi reported 1 open-market purchase totaling $677 in EVGN and no open-market sales.
Companies traded
Other insiders at EVGN
Insider Buying
$677
reported purchases (SEC code P)
Insider Selling
$0
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Tarcic Gabi made?
Tarcic Gabi has filed 1 SEC Form 4 filing (1 transaction rows) across 1 company since 2026.
Which companies does Tarcic Gabi trade?
Tarcic Gabi has filed SEC Form 4 disclosures for 1 company, including EVGN.
When was Tarcic Gabi's most recent SEC Form 4 filing?
Tarcic Gabi's most recent SEC Form 4 filing on Tracefour is dated Aug 26, 2026.
What is Tarcic Gabi's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Tarcic Gabi is listed as Chief Development Officer.
What is Tarcic Gabi's total buy and sell value in the current window?
Inside the rolling retention window, Tarcic Gabi bought $677 and sold $0 based on SEC Form 4 filings.
What was Tarcic Gabi's largest disclosed transaction?
The largest disclosed transaction in the current window is a purchase of 1,129 EVGN shares on 2026-06-04, worth $677, per SEC Form 4 filings.